Linopirdine

Revision as of 18:19, 10 April 2015 by Turky Alkathery (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Linopirdine
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC26H21N3O
Molar mass391.465 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Linopirdine is a putative cognition-enhancing drug with a novel mechanism of action. Linopirdine blocks the KCNQ2\3 heteromer M current with an IC50 of 2.4nM[1] disinhibiting acetylcholine release, and increasing hippocampal CA3-schaffer collateral mediated glutamate release onto CA1 pyramidal neurons.[2] In a murine model linopirdine is able to nearly completely reverse the senescence-related decline in cortical c-FOS, an effect which is blocked by atropine and MK-801, suggesting Linopirdine can compensate for the age related decline in acetylcholine release.[3] Linopirdine also blocks homomeric KCNQ1 and KCNQ4 voltage gated potassium channels which contribute to vascular tone with substantially less selectivity than KCNQ2/3.[1]

References

  1. 1.0 1.1 PMID 9694925 (PMID 9694925)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  2. PMID 22674722 (PMID 22674722)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  3. PMID 11378256 (PMID 11378256)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

Template:Nootropics Template:Channel blockers